[Apolipoprotein E4 and late-onset Alzheimer's disease]

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Context:

• Apolipoprotein E (APOE) is a plasma protein crucial for cholesterol transport.
• APOE is also produced by glial cells and plays a role in nervous system repair.
• APOE is implicated in the pathology of Alzheimer's disease (AD), including amyloid plaques and neurofibrillary tangles (NFTs).

Purpose:

• To investigate the role of Apolipoprotein E (APOE) and its genetic variants in Alzheimer's disease (AD).
• To examine the interaction of APOE with amyloid-beta (Aβ) and tau proteins.
• To understand the differential binding affinities of APOE variants to Aβ and tau.

Summary:

• APOE immunoreactivity is found in amyloid deposits and NFTs in AD brains.
• Three common APOE alleles (epsilon 4, epsilon 3, and epsilon 2) exist, differing by single amino acid substitutions.
• The APOE-epsilon 4 allele is associated with increased risk for all forms of AD, while APOE-epsilon 2 may be protective.
• APOE binds to amyloid-beta (Aβ), with faster binding observed for APOE-E4 compared to APOE-E3.
• APOE-E3 also binds to tau, potentially inhibiting NFT formation.

Impact:

• The APOE genotype is a significant genetic factor influencing Alzheimer's disease susceptibility.
• Understanding APOE's interaction with Aβ and tau provides insights into AD pathogenesis.
• This research highlights APOE's complex role in both normal brain function and neurodegenerative disease.